Bill Mayo

Bill’s practice involves all aspects of intellectual property law, including strategic advice, litigation, trademark oppositions, and clearance and validity opinions. Bill has extensive experience advising pharmaceutical companies with respect to IP and regulatory issues, including with respect to the Patented Medicines (Notice of Compliance) Regulations,

A registered Canadian Patent and Trademark agent, Bill is the past-President of AIPPI Canada, the Canadian Group of the International Association for the Protection of Intellectual Property. He has been recognized as a leader in intellectual property in Chambers Global: The World’s Leading Lawyers for Business, and as one of the best Canadian patent lawyers by Who’s Who Legal and in The Best Lawyers in Canada (Woodward/White). Bill has also been recognized by Martindale Hubbell and included in Intellectual Management’s IAM Patent 1000 – The World’s Leading Patent Practitioners and in the Canadian Legal Lexpert Directory.

Bill has been involved in numerous important intellectual property litigation cases. Bill received international recognition from Managing Intellectual Property magazine for his work on Sanofi-Aventis Inc. v. Novopharm Ltd., 2007 FCA 163, the Canadian IP Case of the Year.

Prior to joining Aitken Klee in 2014, Bill practiced intellectual property law with firms in Toronto and Ottawa and as in-house IP counsel at Newbridge Networks.